Skip to main content
Menu
background1
Home » News and Events » Cutting Edge Glaucoma Technology

Cutting Edge Glaucoma Technology

clipart 046

Some 2.5 million North Americans struggle with glaucoma, a progressive eye disease that robs its sufferers of their vision, if unmanaged. Associated with high eye pressure and damage to the optic nerve, the main method of preventing blindness and low vision from glaucoma is by maintaining low levels of IOP (intraocular pressure). Unstable glaucoma may require frequent visits to an eye doctor for glaucoma monitoring to keep it under control.

In recent years a parallel disorder, high blood pressure, has become widely known for producing results that vary significantly, even from hour to hour. Both blood pressure and eye pressure can be affected by such a wide range of environmental and other factors – from the way you stand to the weather – that taking a single reading on a given day may not provide a good indication of patient health.

The need for more accurate diagnostic tools has prompted researchers at Stanford University and Bar Ilan University to collaborate in the development of a 24-hour a day IOP monitor for glaucoma patients. The device, which eye doctors hope will be available within a few years, is actually an eye implant!

It is so tiny, it’s designed to fit inside a standard intraocular lens – the kind used in cataract surgery – and, according to tests conducted by the U.S. Air Force, it will not distort vision.

The implanted glaucoma monitor is based on simple physics, using fluid levels in a tiny tube to precisely measure IOP. When available to the public, it may be paired with a custom smartphone app or wearable technology like Google glass to record eye pressure all the time, and the data can be shared with the patient’s ophthalmologist or optometrist.

Recent studies indicated that round-the-clock IOP monitoring would result in modified treatment for up to 80% of patients. Prevention of intraocular pressure spikes by measuring IOP throughout a 24 hour cycle would enable eye doctors to optimize a treatment plan. Since peripheral vision loss from optic nerve damage is not reversible, treatment is aimed at preventing vision loss from glaucoma. 

x

Personal Message from Drs. McRoberts, Bowden & Davidson regarding COVID-19

Considering the evolving situation of COVID-19, we feel it is our responsibility to prioritize the health of our community members during this critical time and do what we can to minimize the opportunity for transmission. As a result, we have made the decision to close our physical clinic and provide only virtual appointments & emergency referrals until further notice.

For Squamish patients, please call 604-892-5055 during our regular business hours to consult.
For West Vancouver patients, please call 604-922- 0413 during our regular business hours to consult.

We are here if you need us!

**Please note – we will continue to be available for your glasses, contacts, eye drops, ocular supplements and any other product or prescription needs. Please call and we can arrange to have these shipped directly to your door at no charge.

Thank you for your support and understanding as we navigate these unprecedented times. We are hopeful that this will be a temporary measure, and will be monitoring the situation carefully. Please take care of yourselves & each other, and we hope to see you soon!

Sincerely,
Drs. McRoberts, Bowden & Davidson